Table 2. MIC50 and MIC90 of staphylococcal antibiotics against community-acquired methicillin resistant Staphylococcus aureus (CA-MRSA) from Europe (46 isolates), United States (22 isolates), and Oceania (13 isolates).
| Antibiotics | Isolates from Europe |
Isolates from United States and Oceania |
||||
|---|---|---|---|---|---|---|
| MIC50 mg/L | MIC90 mg/L | Range mg/L | MIC50 mg/L | MIC90 mg/L | Range mg/L | |
| Benzyl-penicillin | 8 | 8 | 0.25–8 | 16 | 16 | 4–32 |
| Oxacillin | 16 | 32 | 4–64 | 64 | 64 | 16–64 |
| Kanamycin | 128 | 128 | 128 | 2 | 2 | 2 |
| Tobramycin | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 |
| Gentamicin | 1 | 1 | 0.5–1 | 1 | 1 | 0.5–2 |
| Erythromycin | 0.5 | 128 | 0.25–128 | 0.25 | 0.5 | 0.25–128 |
| Lincomycin | 0.5 | 0.5 | 0.5–32 | 0.5 | 0.5 | 0.25–32 |
| Pristinamycin | 0.5 | 0.5 | 0.12–1 | 0.5 | 0.5 | 0.12–1 |
| Tetracycline | 16 | 16 | 0.25–16 | 0.25 | 0.25 | 0.25–32 |
| Minocycline | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 | 0.25 |
| Chloramphenicol | 4 | 4 | 4–8 | 4 | 8 | 4–8 |
| Ofloxacin | 0.12 | 0.12 | 0.12–0.5 | 0.12 | 0.25 | 0.12–1 |
| Fusidic acid | 4 | 4 | 0.12–64 | 0.12 | 0.12 | 0.12 |
| Vancomycin | 0.5 | 0;5 | 0.5–1 | 0.5 | 0;5 | 0.5–1 |
| Teicoplanin | 0.5 | 0.5 | 0.25–0.5 | 0.25 | 0.5 | 0.25–0.5 |
| Fosfomycin | 2 | 2 | 0.25–2 | 1 | 2 | 0.25–2 |
| Rifampin | 0.12 | 0.12 | 0.12 | 0.12 | 0.12 | 0.12 |
| Co-trimoxazole | 0.5/9.5 | 0.5/9.5 | 0.5/9.5 | 0.5/9.5 | 0.5/9.5 | 0.5/9.5 |
| Linezolid | 0.5 | 1 | 0.25–1 | 0.5 | 1 | 0.25–1 |
| Mupirocin | 0.12 | 0.12 | 0.12–8 | 0.12 | 0.12 | 0.12 |